Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
2,416
JPY
|
+0.86%
|
|
+3.85%
|
-9.29%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
156,406
|
129,800
|
211,857
|
165,227
|
151,722
|
137,275
|
-
|
-
|
Enterprise Value (EV)
1 |
172,623
|
164,967
|
249,351
|
191,736
|
184,700
|
174,379
|
172,037
|
169,063
|
P/E ratio
|
24.5
x
|
-251
x
|
12.1
x
|
5.59
x
|
9.68
x
|
-630
x
|
24.6
x
|
18.5
x
|
Yield
|
4.73%
|
5.71%
|
3.88%
|
4.3%
|
4.69%
|
5.17%
|
5.18%
|
5.2%
|
Capitalization / Revenue
|
0.86
x
|
0.69
x
|
0.95
x
|
0.61
x
|
0.58
x
|
0.58
x
|
0.56
x
|
0.54
x
|
EV / Revenue
|
0.95
x
|
0.87
x
|
1.12
x
|
0.7
x
|
0.71
x
|
0.73
x
|
0.7
x
|
0.66
x
|
EV / EBITDA
|
7.09
x
|
7.76
x
|
6.58
x
|
2.94
x
|
4.29
x
|
8.07
x
|
5.43
x
|
5.03
x
|
EV / FCF
|
-113
x
|
-45.8
x
|
34.1
x
|
7.87
x
|
62.6
x
|
45.6
x
|
13
x
|
11.8
x
|
FCF Yield
|
-0.88%
|
-2.18%
|
2.93%
|
12.7%
|
1.6%
|
2.19%
|
7.68%
|
8.44%
|
Price to Book
|
1.39
x
|
1.26
x
|
1.84
x
|
1.18
x
|
1.01
x
|
0.97
x
|
0.98
x
|
0.98
x
|
Nbr of stocks (in thousands)
|
56,958
|
56,980
|
57,027
|
56,877
|
56,910
|
56,819
|
-
|
-
|
Reference price
2 |
2,746
|
2,278
|
3,715
|
2,905
|
2,666
|
2,416
|
2,416
|
2,416
|
Announcement Date
|
5/14/19
|
5/13/20
|
5/14/21
|
5/12/22
|
5/12/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
181,415
|
188,712
|
223,016
|
272,944
|
260,908
|
238,301
|
245,863
|
255,200
|
EBITDA
1 |
24,352
|
21,269
|
37,886
|
65,116
|
43,075
|
21,621
|
31,659
|
33,580
|
EBIT
1 |
14,648
|
9,939
|
25,392
|
50,490
|
23,381
|
834.3
|
9,450
|
12,795
|
Operating Margin
|
8.07%
|
5.27%
|
11.39%
|
18.5%
|
8.96%
|
0.35%
|
3.84%
|
5.01%
|
Earnings before Tax (EBT)
1 |
11,375
|
6,113
|
20,823
|
41,323
|
22,907
|
-1,800
|
5,900
|
9,950
|
Net income
1 |
6,386
|
-516
|
17,468
|
29,599
|
15,676
|
-217.1
|
5,595
|
7,920
|
Net margin
|
3.52%
|
-0.27%
|
7.83%
|
10.84%
|
6.01%
|
-0.09%
|
2.28%
|
3.1%
|
EPS
2 |
111.9
|
-9.060
|
306.4
|
519.6
|
275.5
|
-3.834
|
98.40
|
130.6
|
Free Cash Flow
1 |
-1,524
|
-3,604
|
7,315
|
24,367
|
2,952
|
3,822
|
13,206
|
14,274
|
FCF margin
|
-0.84%
|
-1.91%
|
3.28%
|
8.93%
|
1.13%
|
1.6%
|
5.37%
|
5.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
19.31%
|
37.42%
|
6.85%
|
17.68%
|
41.71%
|
42.51%
|
FCF Conversion (Net income)
|
-
|
-
|
41.88%
|
82.32%
|
18.83%
|
-
|
236.03%
|
180.22%
|
Dividend per Share
2 |
130.0
|
130.0
|
144.0
|
125.0
|
125.0
|
125.0
|
125.2
|
125.5
|
Announcement Date
|
5/14/19
|
5/13/20
|
5/14/21
|
5/12/22
|
5/12/23
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
93,480
|
98,566
|
70,247
|
133,739
|
64,142
|
75,063
|
65,331
|
68,750
|
134,081
|
66,882
|
59,945
|
56,620
|
59,923
|
116,543
|
60,968
|
60,489
|
59,200
|
59,900
|
60,500
|
59,400
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
13,855
|
-
|
11,242
|
4,947
|
-
|
5,270
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
5,758
|
8,146
|
14,724
|
26,951
|
9,220
|
14,319
|
8,580
|
9,104
|
17,684
|
5,966
|
-269
|
-1,711
|
142
|
-1,569
|
422
|
2,247
|
1,300
|
1,500
|
1,900
|
1,100
|
Operating Margin
|
6.16%
|
8.26%
|
20.96%
|
20.15%
|
14.37%
|
19.08%
|
13.13%
|
13.24%
|
13.19%
|
8.92%
|
-0.45%
|
-3.02%
|
0.24%
|
-1.35%
|
0.69%
|
3.71%
|
2.2%
|
2.5%
|
3.14%
|
1.85%
|
Earnings before Tax (EBT)
|
3,965
|
6,160
|
13,675
|
25,090
|
8,626
|
7,607
|
8,128
|
12,574
|
20,702
|
5,084
|
-2,879
|
-1,165
|
-425
|
-1,590
|
-1,646
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
2,544
|
5,102
|
11,176
|
19,519
|
5,999
|
4,081
|
5,587
|
9,966
|
15,553
|
3,236
|
-3,113
|
-1,120
|
-702
|
-1,822
|
-1,523
|
1,445
|
700
|
900
|
800
|
800
|
Net margin
|
2.72%
|
5.18%
|
15.91%
|
14.59%
|
9.35%
|
5.44%
|
8.55%
|
14.5%
|
11.6%
|
4.84%
|
-5.19%
|
-1.98%
|
-1.17%
|
-1.56%
|
-2.5%
|
2.39%
|
1.18%
|
1.5%
|
1.32%
|
1.35%
|
EPS
2 |
44.67
|
89.52
|
-
|
342.2
|
105.4
|
-
|
98.25
|
-
|
273.4
|
56.84
|
-
|
-19.67
|
-12.33
|
-32.00
|
-26.78
|
30.66
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
65.00
|
50.00
|
-
|
62.00
|
-
|
-
|
-
|
-
|
62.00
|
-
|
-
|
-
|
62.00
|
62.00
|
-
|
63.00
|
-
|
62.50
|
-
|
62.50
|
Announcement Date
|
11/11/19
|
11/10/20
|
11/9/21
|
11/9/21
|
2/8/22
|
5/12/22
|
8/9/22
|
11/9/22
|
11/9/22
|
2/8/23
|
5/12/23
|
8/8/23
|
11/9/23
|
11/9/23
|
2/9/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
16,217
|
35,167
|
37,494
|
26,509
|
32,978
|
37,104
|
34,762
|
31,788
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.6659
x
|
1.653
x
|
0.9897
x
|
0.4071
x
|
0.7656
x
|
1.716
x
|
1.098
x
|
0.9466
x
|
Free Cash Flow
1 |
-1,524
|
-3,604
|
7,315
|
24,367
|
2,952
|
3,822
|
13,206
|
14,274
|
ROE (net income / shareholders' equity)
|
5.7%
|
-0.5%
|
16%
|
23.2%
|
10.8%
|
-0.12%
|
3.9%
|
5.58%
|
ROA (Net income/ Total Assets)
|
6.11%
|
3.08%
|
10.8%
|
17.6%
|
7.53%
|
-0.5%
|
2.4%
|
3.9%
|
Assets
1 |
104,541
|
-16,779
|
161,984
|
168,317
|
208,151
|
43,429
|
233,138
|
203,077
|
Book Value Per Share
2 |
1,980
|
1,809
|
2,020
|
2,463
|
2,635
|
2,495
|
2,456
|
2,461
|
Cash Flow per Share
2 |
264.0
|
174.0
|
518.0
|
775.0
|
618.0
|
478.0
|
496.0
|
525.0
|
Capex
1 |
17,768
|
18,833
|
27,375
|
41,654
|
22,558
|
19,233
|
15,767
|
15,933
|
Capex / Sales
|
9.79%
|
9.98%
|
12.27%
|
15.26%
|
8.65%
|
8.07%
|
6.41%
|
6.24%
|
Announcement Date
|
5/14/19
|
5/13/20
|
5/14/21
|
5/12/22
|
5/12/23
|
-
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
2,416
JPY Average target price
2,582
JPY Spread / Average Target +6.87% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.29% | 872M | | -17.89% | 8.25B | | +39.20% | 3.57B | | -39.11% | 2.46B | | -8.06% | 2.46B | | -7.35% | 2.38B | | -12.61% | 1.81B | | -19.01% | 1.55B | | -40.66% | 1.21B | | +7.56% | 1.11B |
Medical & Diagnostic Laboratories
|